KennethLim personal page - To The Moon

KennethLim

KennethLim

No personal profile

30Follow

12Followers

0Topic

0Badge

06-09

06-08

$Frencken(E28.SI)$ semiconductor counter rat i investment in. Looking for good return....

06-08

$Keppel DC Reit(AJBU.SI)$ :)

03-21

$Keppel DC Reit(AJBU.SI)$ nice!!

2024-01-17

$Frencken(E28.SI)$

2023-12-13

$Frencken(E28.SI)$

2023-01-07

Ha!

China in Talks With Pfizer for Generic COVID Drug

2023-01-07

K

Sorry, the original content has been removed

2022-11-22

Ok

3 Stocks to Avoid This Week

2022-10-25

k

@TigerEvents:[REWARDS] How has your stock performed this year?

2022-09-28

Thanks

2022-09-15

$OVERSEA-CHINESE BANKING CORP(O39.SI)$i like ocbc with his stable income & dividend. Price is stable and not volatile. Good to keep for long term.

2022-09-14

$NIO Inc.(NIO.SI)$good run for Nio, from 18 to 21 & heading to 22

2022-09-13

$Apple(AAPL)$i didn't monitorvfor months & the price goes up for 10%!

2022-09-12

$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$JIUTIAN

2022-09-12

$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$JIUTIAN

2022-09-11

$UMS HOLDINGS LIMITED(558.SI)$ums common!!!!

2022-09-11

$UMS HOLDINGS LIMITED(558.SI)$ums

2022-09-10

$UMS HOLDINGS LIMITED(558.SI)$my fav

2022-09-10

$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$stuck

Go to Tiger App to see more news

Invest in Global Markets with Tiger Brokers!

Open App

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3573516985440152","uuid":"3573516985440152","gmtCreate":1610430742833,"gmtModify":1662610003668,"name":"KennethLim","pinyin":"kennethlim","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":12,"headSize":30,"tweetSize":361,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":4,"name":"文化虎","nameTw":"文化虎","represent":"学有所成","factor":"发布30条非转发主帖,其中3条优质帖","iconColor":"8867FB","bgColor":"BDC5FF"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.12","exceedPercentage":"60.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"60.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":444272079331432,"gmtCreate":1749489350385,"gmtModify":1749489354044,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a>&nbsp;","text":"$UMS(558.SI)$","images":[{"img":"https://community-static.tradeup.com/news/b5e093c70b843d26c75bd3889e544966","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/444272079331432","isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581727244675977","authorId":"3581727244675977","name":"MySGX","avatar":"https://static.tigerbbs.com/f6a22f88deb287b757cb3e60419d2882","crmLevel":6,"crmLevelSwitch":0,"idStr":"3581727244675977","authorIdStr":"3581727244675977"},"content":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends","text":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends","html":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":443734981009448,"gmtCreate":1749346073648,"gmtModify":1749346077683,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a> semiconductor counter rat i investment in.&nbsp; Looking for good return....","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a> semiconductor counter rat i investment in.&nbsp; Looking for good return....","text":"$Frencken(E28.SI)$ semiconductor counter rat i investment in. Looking for good return....","images":[{"img":"https://community-static.tradeup.com/news/d1627058710c089ed38365e4ca6d51c7","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/443734981009448","isVote":1,"tweetType":1,"viewCount":90,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":443656887021584,"gmtCreate":1749345938476,"gmtModify":1749345942140,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> :)","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> :)","text":"$Keppel DC Reit(AJBU.SI)$ :)","images":[{"img":"https://community-static.tradeup.com/news/dc7096faf3c4cfea8ec6818228ed3b5e","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/443656887021584","isVote":1,"tweetType":1,"viewCount":32,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":415702547005824,"gmtCreate":1742519016654,"gmtModify":1742519020808,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","text":"$Keppel DC Reit(AJBU.SI)$ nice!!","images":[{"img":"https://community-static.tradeup.com/news/d0d1188dbf2539809188be6f6779e531","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/415702547005824","isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":263853833371928,"gmtCreate":1705453103928,"gmtModify":1705453106955,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","text":"$Frencken(E28.SI)$","images":[{"img":"https://community-static.tradeup.com/news/96efe3c78fd28659b4688e50d9328648","width":"870","height":"1708"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263853833371928","isVote":1,"tweetType":1,"viewCount":1293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":251461901549624,"gmtCreate":1702429277621,"gmtModify":1702429280415,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","text":"$Frencken(E28.SI)$","images":[{"img":"https://community-static.tradeup.com/news/b1ca05d8e617f01acd009bfbe5ab85d4","width":"870","height":"1708"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/251461901549624","isVote":1,"tweetType":1,"viewCount":942,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9959735123,"gmtCreate":1673065107762,"gmtModify":1676538783116,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"Ha!","listText":"Ha!","text":"Ha!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9959735123","repostId":"2301748452","repostType":4,"repost":{"id":"2301748452","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1673046905,"share":"https://ttm.financial/m/news/2301748452?lang=&edition=full_marsco","pubTime":"2023-01-07 07:15","market":"us","language":"en","title":"China in Talks With Pfizer for Generic COVID Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2301748452","media":"Reuters","summary":"HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will","content":"<html><head></head><body><p>HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm&#39;s COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.</p><p>China&#39;s medical products regulator - the National Medical Products Administration (NMPA) - has been leading the talks with Pfizer since late last month, one of the sources with knowledge of the matter said.</p><p>Beijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan. 22, the source said.</p><p>Chinese hospitals are under intense pressure after the government abruptly abandoned its &#34;zero-COVID&#34; policy last month, sending infections soaring. The surging wave of infections across the country has overwhelmed hospitals, emptied pharmacies of medicines and caused international alarm.</p><p>Paxlovid, found to have reduced hospitalisations in high-risk patients by around 90% in a clinical trial, is in high demand with many Chinese attempting to get the drug abroad and have it shipped to China. Beijing has been largely resistant to western vaccines and treatments. Oral treatment Paxlovid is one of the few foreign ones it has approved.</p><p>In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available.</p><p>The NMPA and the State Council Information Office, which handles media queries for the government, did not respond to Reuters requests for comment.</p><p>A Pfizer spokesperson said the company is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China.</p><p>All the sources declined to be identified as they are not authorised to speak to media.</p><p>The NMPA held a meeting with several Chinese drugmakers in late December to discuss preparations needed to make a generic version of Paxlovid hoping it would be able to secure the licence in the near future, two of the sources said.</p><p>Zhejiang Huahai Pharmaceutical, which signed a deal with Pfizer in August to produce Paxlovid only for use on the mainland, and CSPC Pharmaceutical Group, a developer of a potential mRNA COVID vaccine, are among those that attended the meeting, the first source said.</p><p>The second source said the NMPA has also advised firms to prepare to register with the regulator to produce the generic version of Paxlovid.</p><h2>GENERIC DRUGMAKERS</h2><p>Prospective candidates including Huahai and CSPC have in recent weeks been conducting &#34;bioequivalence tests&#34;, which are required by Chinese regulators before generic drugs can be launched, the two sources and another source with direct knowledge of the matter said.</p><p>For a generic drug to be deemed equivalent to a branded medicine, such tests are required to make sure they work the same way in the body.</p><p>Both Huahai and CSPC expect to submit the tests results to the NMPA later this month, one of them added.</p><p>Huahai and CSPC did not respond to a request for comment.</p><p>In March, 35 generic drugmakers around the world including five Chinese firms agreed to make cheap versions of Paxlovid for 95 poorer countries through a licensing arrangement with the U.N.-backed Medicines Patent Pool (MPP). That licence does not allow the companies to sell generic Paxlovid in China.</p><p>The MPP licensing arrangement is royalty free for Pfizer, while COVID-19 remains classified as a &#34;Public Health Emergency of International Concern&#34; by the World Health Organization (WHO).</p><p>Following the pandemic period, sales to low-income countries will remain royalty free, lower-middle-income countries and upper-middle-income countries will be subject to a 5% royalty for sales to the public sector and a 10% royalty for sales to the private sector, MPP said at that time.</p><p>Due to severe shortages of antivirals as 1.4 billion Chinese battle infections, many have turned to underground channels to secure Paxlovid and other drugs, according to domestic media. Scalpers charge as much as 50,000 yuan ($7,260) for a box of Paxlovid, more than 20 times its original price of 2,300 yuan.</p><p>China has also pressed Pfizer to lower the price of Paxlovid as the government aims to include the drug in the national medical insurance scheme which could cover part of the cost, the three sources said.</p><p>($1 = 6.8875 Chinese yuan)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China in Talks With Pfizer for Generic COVID Drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina in Talks With Pfizer for Generic COVID Drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-01-07 07:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm&#39;s COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.</p><p>China&#39;s medical products regulator - the National Medical Products Administration (NMPA) - has been leading the talks with Pfizer since late last month, one of the sources with knowledge of the matter said.</p><p>Beijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan. 22, the source said.</p><p>Chinese hospitals are under intense pressure after the government abruptly abandoned its &#34;zero-COVID&#34; policy last month, sending infections soaring. The surging wave of infections across the country has overwhelmed hospitals, emptied pharmacies of medicines and caused international alarm.</p><p>Paxlovid, found to have reduced hospitalisations in high-risk patients by around 90% in a clinical trial, is in high demand with many Chinese attempting to get the drug abroad and have it shipped to China. Beijing has been largely resistant to western vaccines and treatments. Oral treatment Paxlovid is one of the few foreign ones it has approved.</p><p>In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available.</p><p>The NMPA and the State Council Information Office, which handles media queries for the government, did not respond to Reuters requests for comment.</p><p>A Pfizer spokesperson said the company is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China.</p><p>All the sources declined to be identified as they are not authorised to speak to media.</p><p>The NMPA held a meeting with several Chinese drugmakers in late December to discuss preparations needed to make a generic version of Paxlovid hoping it would be able to secure the licence in the near future, two of the sources said.</p><p>Zhejiang Huahai Pharmaceutical, which signed a deal with Pfizer in August to produce Paxlovid only for use on the mainland, and CSPC Pharmaceutical Group, a developer of a potential mRNA COVID vaccine, are among those that attended the meeting, the first source said.</p><p>The second source said the NMPA has also advised firms to prepare to register with the regulator to produce the generic version of Paxlovid.</p><h2>GENERIC DRUGMAKERS</h2><p>Prospective candidates including Huahai and CSPC have in recent weeks been conducting &#34;bioequivalence tests&#34;, which are required by Chinese regulators before generic drugs can be launched, the two sources and another source with direct knowledge of the matter said.</p><p>For a generic drug to be deemed equivalent to a branded medicine, such tests are required to make sure they work the same way in the body.</p><p>Both Huahai and CSPC expect to submit the tests results to the NMPA later this month, one of them added.</p><p>Huahai and CSPC did not respond to a request for comment.</p><p>In March, 35 generic drugmakers around the world including five Chinese firms agreed to make cheap versions of Paxlovid for 95 poorer countries through a licensing arrangement with the U.N.-backed Medicines Patent Pool (MPP). That licence does not allow the companies to sell generic Paxlovid in China.</p><p>The MPP licensing arrangement is royalty free for Pfizer, while COVID-19 remains classified as a &#34;Public Health Emergency of International Concern&#34; by the World Health Organization (WHO).</p><p>Following the pandemic period, sales to low-income countries will remain royalty free, lower-middle-income countries and upper-middle-income countries will be subject to a 5% royalty for sales to the public sector and a 10% royalty for sales to the private sector, MPP said at that time.</p><p>Due to severe shortages of antivirals as 1.4 billion Chinese battle infections, many have turned to underground channels to secure Paxlovid and other drugs, according to domestic media. Scalpers charge as much as 50,000 yuan ($7,260) for a box of Paxlovid, more than 20 times its original price of 2,300 yuan.</p><p>China has also pressed Pfizer to lower the price of Paxlovid as the government aims to include the drug in the national medical insurance scheme which could cover part of the cost, the three sources said.</p><p>($1 = 6.8875 Chinese yuan)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","PFE":"辉瑞","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999002232.USD":"Allianz Global High Payout USD","LU0058720904.USD":"联博国际健康护理基金A","SG9999002224.SGD":"Allianz Global High Payout SGD","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","BK4581":"高盛持仓","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4124":"机动车零配件与设备","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0122379950.USD":"贝莱德世界健康科学A2","SG9999001176.USD":"United Global Healthcare Acc USD","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","BK4007":"制药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2301748452","content_text":"HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.China's medical products regulator - the National Medical Products Administration (NMPA) - has been leading the talks with Pfizer since late last month, one of the sources with knowledge of the matter said.Beijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan. 22, the source said.Chinese hospitals are under intense pressure after the government abruptly abandoned its \"zero-COVID\" policy last month, sending infections soaring. The surging wave of infections across the country has overwhelmed hospitals, emptied pharmacies of medicines and caused international alarm.Paxlovid, found to have reduced hospitalisations in high-risk patients by around 90% in a clinical trial, is in high demand with many Chinese attempting to get the drug abroad and have it shipped to China. Beijing has been largely resistant to western vaccines and treatments. Oral treatment Paxlovid is one of the few foreign ones it has approved.In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available.The NMPA and the State Council Information Office, which handles media queries for the government, did not respond to Reuters requests for comment.A Pfizer spokesperson said the company is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China.All the sources declined to be identified as they are not authorised to speak to media.The NMPA held a meeting with several Chinese drugmakers in late December to discuss preparations needed to make a generic version of Paxlovid hoping it would be able to secure the licence in the near future, two of the sources said.Zhejiang Huahai Pharmaceutical, which signed a deal with Pfizer in August to produce Paxlovid only for use on the mainland, and CSPC Pharmaceutical Group, a developer of a potential mRNA COVID vaccine, are among those that attended the meeting, the first source said.The second source said the NMPA has also advised firms to prepare to register with the regulator to produce the generic version of Paxlovid.GENERIC DRUGMAKERSProspective candidates including Huahai and CSPC have in recent weeks been conducting \"bioequivalence tests\", which are required by Chinese regulators before generic drugs can be launched, the two sources and another source with direct knowledge of the matter said.For a generic drug to be deemed equivalent to a branded medicine, such tests are required to make sure they work the same way in the body.Both Huahai and CSPC expect to submit the tests results to the NMPA later this month, one of them added.Huahai and CSPC did not respond to a request for comment.In March, 35 generic drugmakers around the world including five Chinese firms agreed to make cheap versions of Paxlovid for 95 poorer countries through a licensing arrangement with the U.N.-backed Medicines Patent Pool (MPP). That licence does not allow the companies to sell generic Paxlovid in China.The MPP licensing arrangement is royalty free for Pfizer, while COVID-19 remains classified as a \"Public Health Emergency of International Concern\" by the World Health Organization (WHO).Following the pandemic period, sales to low-income countries will remain royalty free, lower-middle-income countries and upper-middle-income countries will be subject to a 5% royalty for sales to the public sector and a 10% royalty for sales to the private sector, MPP said at that time.Due to severe shortages of antivirals as 1.4 billion Chinese battle infections, many have turned to underground channels to secure Paxlovid and other drugs, according to domestic media. Scalpers charge as much as 50,000 yuan ($7,260) for a box of Paxlovid, more than 20 times its original price of 2,300 yuan.China has also pressed Pfizer to lower the price of Paxlovid as the government aims to include the drug in the national medical insurance scheme which could cover part of the cost, the three sources said.($1 = 6.8875 Chinese yuan)","news_type":1},"isVote":1,"tweetType":1,"viewCount":1084,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9959735976,"gmtCreate":1673065098195,"gmtModify":1676538783109,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9959735976","repostId":"1199658349","repostType":4,"isVote":1,"tweetType":1,"viewCount":1304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9968020335,"gmtCreate":1669079289627,"gmtModify":1676538148147,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9968020335","repostId":"2285904055","repostType":4,"repost":{"id":"2285904055","kind":"highlight","pubTimestamp":1669089004,"share":"https://ttm.financial/m/news/2285904055?lang=&edition=full_marsco","pubTime":"2022-11-22 11:50","market":"us","language":"en","title":"3 Stocks to Avoid This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2285904055","media":"Motley Fool","summary":"These investments seem pretty vulnerable right now.","content":"<html><head></head><body><p>Last week was a letdown for investors long the market after a strong rally the week before. The &#34;three stocks to avoid&#34; in my column that I thought were going to lose to the market last week -- <b>Coinbase</b>, <b>Despegar.com</b>, and <b><a href=\"https://laohu8.com/S/BOWL\">Bowlero</a></b> -- fell 21%, 12%, and 12%, respectively, averaging out to a 15% plunge.</p><p>The <b>S&amp;P 500</b> experienced only a 0.7% move lower. I was right. I have been correct in 36 of the past 57 weeks, or 63% of the time.</p><p>Now let&#39;s look at the week ahead. I see <b>Best Buy</b>, <b>Luckin Coffee</b>, and <b>Apple</b> as stocks you might want to consider steering clear of this week. Let&#39;s go over my near-term concerns with all three investments.</p><h2><b>1. Best Buy</b></h2><p>Best Buy&#39;s revival a few years ago was a thing of beauty. Now we&#39;re seeing that the last major consumer-electronics superstore chain still standing is on wobbly legs.</p><p>The retailer reports fresh financials on Tuesday morning, and it won&#39;t be pretty. Analysts see revenue clocking in 13% lower than the prior-year&#39;s fiscal third quarter. Its profit is expected to be cut in half.</p><p>The near-term outlook is uninspiring. Wall Street pros see revenue slipping 11% for the current holiday quarter, as well as the entire fiscal 2023 year that ends in January. Profitability should take a bigger hit. If you&#39;re buying Best Buy for that chunky 4.9% yield, that&#39;s a dicey proposition when its bottom line is going the wrong way.</p><p>Rising costs and the inability of a brick-and-mortar chain to compete on price with bare-boned online merchants are making life hard for Best Buy, again. Now we have a potentially dimming economy setting back demand for consumer electronics.</p><p>To be fair, Best Buy&#39;s renaissance wasn&#39;t that exciting. You have to go back to fiscal 2009 -- 14 years -- to find the last time that this chain delivered top-line gains in the double digits.</p><h2><b>2. Luckin Coffee</b></h2><p>If you were to construct the perfect stock to avoid in a lab, it would probably look a lot like Luckin Coffee. It&#39;s a China-based company at a time when most investors outside of the country are steering clear of the market.</p><p>Let&#39;s also not forget that Luckin Coffee is a stock that -- like its hot java -- already burned investors before. You surely remember the accounting scandal of 2020.</p><p>Have you checked on Luckin Coffee stock lately? The stock is a 20-bagger off its C-suite drama low. The shares ended this past week within 0.5% of a new two-year high, nearly quadrupling from this-year&#39;s springtime bottom. We&#39;ll get an update on how it&#39;s brewing when it pours a cup of third-quarter results on Tuesday.</p><p>Luckin Coffee has done a commendable job turning things around. After years of losses, it was profitable in 2021. Revenue continued to grow.</p><p>However, Luckin Coffee&#39;s top-line gains have decelerated for four consecutive quarters. It also posted a loss in its previous quarter. It&#39;s hard to get excited about Luckin Coffee. It may seem like a low-priced indulgence, but it&#39;s a luxury that consumers will avoid if they need to save their money for more-pressing expenses.</p><h2><b>3. Apple</b></h2><p>Let&#39;s wrap-up this-week&#39;s list by picking on the country&#39;s most valuable company by market cap. I&#39;m a longtime fan and investor in Apple, but I can see why it&#39;s a scary stock to hold heading into this particular holiday shopping season. The economy is on iffy footing, credit card debit is rising, and Apple isn&#39;t going to be immune from consumers steering clear of big-ticket purchases this season.</p><p>Apple held up well when most tech stocks got slammed earlier this year, but the class act of Cupertino is finally proving mortal. It doesn&#39;t help that its annual refresh of popular products wasn&#39;t overly impressive. With money already tight, it&#39;s easy to see consumers ride this year out and see what Apple springs on us in 2023.</p><p>Analysts aren&#39;t excited. They see revenue and earnings per share rising a mere 3% and 2%, respectively, for the new fiscal year.</p><p>It&#39;s going to be a bumpy road for some of these investments. If you&#39;re looking for safe stocks, you aren&#39;t likely to find them in Best Buy, Luckin Coffee, and Apple this week.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Avoid This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Avoid This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-22 11:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last week was a letdown for investors long the market after a strong rally the week before. The \"three stocks to avoid\" in my column that I thought were going to lose to the market last week -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LKNCY":"瑞幸咖啡","AAPL":"苹果","BBY":"百思买"},"source_url":"https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2285904055","content_text":"Last week was a letdown for investors long the market after a strong rally the week before. The \"three stocks to avoid\" in my column that I thought were going to lose to the market last week -- Coinbase, Despegar.com, and Bowlero -- fell 21%, 12%, and 12%, respectively, averaging out to a 15% plunge.The S&P 500 experienced only a 0.7% move lower. I was right. I have been correct in 36 of the past 57 weeks, or 63% of the time.Now let's look at the week ahead. I see Best Buy, Luckin Coffee, and Apple as stocks you might want to consider steering clear of this week. Let's go over my near-term concerns with all three investments.1. Best BuyBest Buy's revival a few years ago was a thing of beauty. Now we're seeing that the last major consumer-electronics superstore chain still standing is on wobbly legs.The retailer reports fresh financials on Tuesday morning, and it won't be pretty. Analysts see revenue clocking in 13% lower than the prior-year's fiscal third quarter. Its profit is expected to be cut in half.The near-term outlook is uninspiring. Wall Street pros see revenue slipping 11% for the current holiday quarter, as well as the entire fiscal 2023 year that ends in January. Profitability should take a bigger hit. If you're buying Best Buy for that chunky 4.9% yield, that's a dicey proposition when its bottom line is going the wrong way.Rising costs and the inability of a brick-and-mortar chain to compete on price with bare-boned online merchants are making life hard for Best Buy, again. Now we have a potentially dimming economy setting back demand for consumer electronics.To be fair, Best Buy's renaissance wasn't that exciting. You have to go back to fiscal 2009 -- 14 years -- to find the last time that this chain delivered top-line gains in the double digits.2. Luckin CoffeeIf you were to construct the perfect stock to avoid in a lab, it would probably look a lot like Luckin Coffee. It's a China-based company at a time when most investors outside of the country are steering clear of the market.Let's also not forget that Luckin Coffee is a stock that -- like its hot java -- already burned investors before. You surely remember the accounting scandal of 2020.Have you checked on Luckin Coffee stock lately? The stock is a 20-bagger off its C-suite drama low. The shares ended this past week within 0.5% of a new two-year high, nearly quadrupling from this-year's springtime bottom. We'll get an update on how it's brewing when it pours a cup of third-quarter results on Tuesday.Luckin Coffee has done a commendable job turning things around. After years of losses, it was profitable in 2021. Revenue continued to grow.However, Luckin Coffee's top-line gains have decelerated for four consecutive quarters. It also posted a loss in its previous quarter. It's hard to get excited about Luckin Coffee. It may seem like a low-priced indulgence, but it's a luxury that consumers will avoid if they need to save their money for more-pressing expenses.3. AppleLet's wrap-up this-week's list by picking on the country's most valuable company by market cap. I'm a longtime fan and investor in Apple, but I can see why it's a scary stock to hold heading into this particular holiday shopping season. The economy is on iffy footing, credit card debit is rising, and Apple isn't going to be immune from consumers steering clear of big-ticket purchases this season.Apple held up well when most tech stocks got slammed earlier this year, but the class act of Cupertino is finally proving mortal. It doesn't help that its annual refresh of popular products wasn't overly impressive. With money already tight, it's easy to see consumers ride this year out and see what Apple springs on us in 2023.Analysts aren't excited. They see revenue and earnings per share rising a mere 3% and 2%, respectively, for the new fiscal year.It's going to be a bumpy road for some of these investments. If you're looking for safe stocks, you aren't likely to find them in Best Buy, Luckin Coffee, and Apple this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1837,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9988141116,"gmtCreate":1666705240836,"gmtModify":1676537793002,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"k","listText":"k","text":"k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988141116","repostId":"9988149248","repostType":1,"repost":{"id":9988149248,"gmtCreate":1666704929585,"gmtModify":1676537792709,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667667103859","authorIdStr":"3527667667103859"},"themes":[],"title":"[REWARDS] How has your stock performed this year?","htmlText":"Hi Tigers:I would like to invite you to share your positions and to win Tiger Coins.Sharing positions is simple. From your account holdings interface, you can click \"Share\" by each of your stock holdings to discuss with the community how much money you have made (or lost) on your investments.Due to the Fed's recent increase in interest rates, many stocks have fallen, particularly the technology sector, which has entered the \"discounting season\" early this year.&nbsp;The share prices of<a href=\"https://ttm.financial/S/GOOG\">$Alphabet(GOOG)$</a> and<a href=\"https://ttm.financial/S/AMZN\">$Amazon.com(AMZN)$</a> have fallen more than 30% so far this year. The share prices of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> have fallen more than 40% so far this year.","listText":"Hi Tigers:I would like to invite you to share your positions and to win Tiger Coins.Sharing positions is simple. From your account holdings interface, you can click \"Share\" by each of your stock holdings to discuss with the community how much money you have made (or lost) on your investments.Due to the Fed's recent increase in interest rates, many stocks have fallen, particularly the technology sector, which has entered the \"discounting season\" early this year.&nbsp;The share prices of<a href=\"https://ttm.financial/S/GOOG\">$Alphabet(GOOG)$</a> and<a href=\"https://ttm.financial/S/AMZN\">$Amazon.com(AMZN)$</a> have fallen more than 30% so far this year. The share prices of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> have fallen more than 40% so far this year.","text":"Hi Tigers:I would like to invite you to share your positions and to win Tiger Coins.Sharing positions is simple. From your account holdings interface, you can click \"Share\" by each of your stock holdings to discuss with the community how much money you have made (or lost) on your investments.Due to the Fed's recent increase in interest rates, many stocks have fallen, particularly the technology sector, which has entered the \"discounting season\" early this year. The share prices of$Alphabet(GOOG)$ and$Amazon.com(AMZN)$ have fallen more than 30% so far this year. The share prices of $Tesla Motors(TSLA)$ have fallen more than 40% so far this year.","images":[{"img":"https://static.tigerbbs.com/b403c20c141980924fa878bf76a65edc","width":"-1","height":"-1"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988149248","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9918343175,"gmtCreate":1664327123597,"gmtModify":1676537433232,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9918343175","isVote":1,"tweetType":1,"viewCount":1263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9934117776,"gmtCreate":1663204159795,"gmtModify":1676537226395,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","listText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$i like ocbc with his stable income & dividend. Price is stable and not volatile. Good to keep for long term.","images":[{"img":"https://community-static.tradeup.com/news/f1c5139ba2b781ed3ce599b8d286dcf5","width":"1080","height":"2672"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":9,"repostSize":0,"link":"https://ttm.financial/post/9934117776","isVote":1,"tweetType":1,"viewCount":1870,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9935435409,"gmtCreate":1663120190001,"gmtModify":1676537208095,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NIO.SI\">$NIO Inc.(NIO.SI)$</a>good run for Nio, from 18 to 21 &amp; heading to 22","listText":"<a href=\"https://ttm.financial/S/NIO.SI\">$NIO Inc.(NIO.SI)$</a>good run for Nio, from 18 to 21 &amp; heading to 22","text":"$NIO Inc.(NIO.SI)$good run for Nio, from 18 to 21 & heading to 22","images":[{"img":"https://community-static.tradeup.com/news/1c3153a4810cf824c1e36ec6afcbe29a","width":"1080","height":"2672"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9935435409","isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9935951126,"gmtCreate":1663028492866,"gmtModify":1676537184953,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>i didn't monitorvfor months &amp; the price goes up for 10%!","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>i didn't monitorvfor months &amp; the price goes up for 10%!","text":"$Apple(AAPL)$i didn't monitorvfor months & the price goes up for 10%!","images":[{"img":"https://community-static.tradeup.com/news/70a6ba79b86bc1ff0af5b5dbc24ed4a4","width":"1080","height":"2233"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9935951126","isVote":1,"tweetType":1,"viewCount":1008,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9932748204,"gmtCreate":1662997052808,"gmtModify":1676537179450,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>JIUTIAN","listText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>JIUTIAN","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$JIUTIAN","images":[{"img":"https://community-static.tradeup.com/news/d6f4d1de132e9ca046259f661303ab4a","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/9932748204","isVote":1,"tweetType":1,"viewCount":1529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9932243175,"gmtCreate":1662948605798,"gmtModify":1676537169451,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>JIUTIAN","listText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>JIUTIAN","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$JIUTIAN","images":[{"img":"https://community-static.tradeup.com/news/8604a473fec95ed7f442600cde95a0b7","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9932243175","isVote":1,"tweetType":1,"viewCount":585,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9932391313,"gmtCreate":1662870459932,"gmtModify":1676537155223,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>ums common!!!!","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>ums common!!!!","text":"$UMS HOLDINGS LIMITED(558.SI)$ums common!!!!","images":[{"img":"https://community-static.tradeup.com/news/ae91968ff3542ca5b0a144deb8f13f01","width":"1080","height":"2489"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9932391313","isVote":1,"tweetType":1,"viewCount":631,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9932393861,"gmtCreate":1662870342354,"gmtModify":1676537155202,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>ums&nbsp;[Happy]&nbsp;","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>ums&nbsp;[Happy]&nbsp;","text":"$UMS HOLDINGS LIMITED(558.SI)$ums [Happy]","images":[{"img":"https://community-static.tradeup.com/news/c5215b9623a8969a369be7573cb1fb05","width":"1080","height":"2489"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9932393861","isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9936585282,"gmtCreate":1662782766946,"gmtModify":1676537140865,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>my fav","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>my fav","text":"$UMS HOLDINGS LIMITED(558.SI)$my fav","images":[{"img":"https://community-static.tradeup.com/news/59edcc799f64c0cd90475990c6181842","width":"1080","height":"2489"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9936585282","isVote":1,"tweetType":1,"viewCount":567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9936585890,"gmtCreate":1662782736510,"gmtModify":1676537140857,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>stuck","listText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>stuck","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$stuck","images":[{"img":"https://community-static.tradeup.com/news/8ea20417bb4abc67b8cb16ea68b6c4fc","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9936585890","isVote":1,"tweetType":1,"viewCount":563,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":9023070238,"gmtCreate":1652840920024,"gmtModify":1676535173322,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"title":"FRENCKEN Group","htmlText":"Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","listText":"Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","text":"Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":29,"commentSize":27,"repostSize":2,"link":"https://ttm.financial/post/9023070238","isVote":1,"tweetType":1,"viewCount":1388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9028085509,"gmtCreate":1653117509501,"gmtModify":1676535227775,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E5H.SI\">$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$</a>no more banned of indo export that create an up movement now... how high can it go?","listText":"<a href=\"https://ttm.financial/S/E5H.SI\">$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$</a>no more banned of indo export that create an up movement now... how high can it go?","text":"$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$no more banned of indo export that create an up movement now... how high can it go?","images":[{"img":"https://community-static.tradeup.com/news/3ba209c693aa5badae8902a8e65f08e7","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":30,"commentSize":28,"repostSize":0,"link":"https://ttm.financial/post/9028085509","isVote":1,"tweetType":1,"viewCount":1226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9023069216,"gmtCreate":1652837488735,"gmtModify":1676535172186,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","text":"$FRENCKEN GROUP LIMITED(E28.SI)$Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","images":[{"img":"https://community-static.tradeup.com/news/f339a24169edf49c049c5fc0638925dc","width":"1080","height":"3642"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":22,"commentSize":18,"repostSize":1,"link":"https://ttm.financial/post/9023069216","isVote":1,"tweetType":1,"viewCount":1621,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":444272079331432,"gmtCreate":1749489350385,"gmtModify":1749489354044,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a>&nbsp;","text":"$UMS(558.SI)$","images":[{"img":"https://community-static.tradeup.com/news/b5e093c70b843d26c75bd3889e544966","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/444272079331432","isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581727244675977","authorId":"3581727244675977","name":"MySGX","avatar":"https://static.tigerbbs.com/f6a22f88deb287b757cb3e60419d2882","crmLevel":6,"crmLevelSwitch":0,"idStr":"3581727244675977","authorIdStr":"3581727244675977"},"content":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends","text":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends","html":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9905365528,"gmtCreate":1659832285366,"gmtModify":1703766791899,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>this seems to be back to 2020 level... will it shut up to sgd2 again?&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>this seems to be back to 2020 level... will it shut up to sgd2 again?&nbsp;","text":"$FRENCKEN GROUP LIMITED(E28.SI)$this seems to be back to 2020 level... will it shut up to sgd2 again?","images":[{"img":"https://community-static.tradeup.com/news/5fdf68a698b1ee7e650adc77e0ef1714","width":"1080","height":"2492"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":18,"commentSize":16,"repostSize":0,"link":"https://ttm.financial/post/9905365528","isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9064933855,"gmtCreate":1652263233877,"gmtModify":1676535064100,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"title":"<<ums-come on>>","htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","text":"$UMS HOLDINGS LIMITED(558.SI)$UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":10,"commentSize":15,"repostSize":0,"link":"https://ttm.financial/post/9064933855","isVote":1,"tweetType":1,"viewCount":444,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000525","authorId":"9000000000000525","name":"JuliusGoldsmith","avatar":"https://static.tigerbbs.com/aa7cf122cebf5a413a760f20bd5fed89","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000525","authorIdStr":"9000000000000525"},"content":"a slightly low level dividend","text":"a slightly low level dividend","html":"a slightly low level dividend"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064081695,"gmtCreate":1652247578617,"gmtModify":1676535061720,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","text":"$UMS HOLDINGS LIMITED(558.SI)$UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":12,"commentSize":11,"repostSize":0,"link":"https://ttm.financial/post/9064081695","isVote":1,"tweetType":1,"viewCount":537,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9938037559,"gmtCreate":1662520139872,"gmtModify":1676537079545,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>SSG border is open yet the results of Genting is not improvement.... what's next?","listText":"<a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>SSG border is open yet the results of Genting is not improvement.... what's next?","text":"$GENTING SINGAPORE LIMITED(G13.SI)$SSG border is open yet the results of Genting is not improvement.... what's next?","images":[{"img":"https://community-static.tradeup.com/news/4bf5bc4377f76edc7a73d1d0e2a52727","width":"1080","height":"2489"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":16,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/9938037559","isVote":1,"tweetType":1,"viewCount":934,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9934117776,"gmtCreate":1663204159795,"gmtModify":1676537226395,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","listText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$i like ocbc with his stable income & dividend. Price is stable and not volatile. Good to keep for long term.","images":[{"img":"https://community-static.tradeup.com/news/f1c5139ba2b781ed3ce599b8d286dcf5","width":"1080","height":"2672"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":9,"repostSize":0,"link":"https://ttm.financial/post/9934117776","isVote":1,"tweetType":1,"viewCount":1870,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":415702547005824,"gmtCreate":1742519016654,"gmtModify":1742519020808,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","text":"$Keppel DC Reit(AJBU.SI)$ nice!!","images":[{"img":"https://community-static.tradeup.com/news/d0d1188dbf2539809188be6f6779e531","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/415702547005824","isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":263853833371928,"gmtCreate":1705453103928,"gmtModify":1705453106955,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","text":"$Frencken(E28.SI)$","images":[{"img":"https://community-static.tradeup.com/news/96efe3c78fd28659b4688e50d9328648","width":"870","height":"1708"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263853833371928","isVote":1,"tweetType":1,"viewCount":1293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9072873486,"gmtCreate":1658021062745,"gmtModify":1676536094029,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/1R6.SI\">$Avi-Tech Hldg(1R6.SI)$</a>avi tech","listText":"<a href=\"https://ttm.financial/S/1R6.SI\">$Avi-Tech Hldg(1R6.SI)$</a>avi tech","text":"$Avi-Tech Hldg(1R6.SI)$avi tech","images":[{"img":"https://community-static.tradeup.com/news/1062690fb99e6e3fabe3b90769638669","width":"1080","height":"3642"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9072873486","isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9968020335,"gmtCreate":1669079289627,"gmtModify":1676538148147,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9968020335","repostId":"2285904055","repostType":4,"repost":{"id":"2285904055","kind":"highlight","pubTimestamp":1669089004,"share":"https://ttm.financial/m/news/2285904055?lang=&edition=full_marsco","pubTime":"2022-11-22 11:50","market":"us","language":"en","title":"3 Stocks to Avoid This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2285904055","media":"Motley Fool","summary":"These investments seem pretty vulnerable right now.","content":"<html><head></head><body><p>Last week was a letdown for investors long the market after a strong rally the week before. The &#34;three stocks to avoid&#34; in my column that I thought were going to lose to the market last week -- <b>Coinbase</b>, <b>Despegar.com</b>, and <b><a href=\"https://laohu8.com/S/BOWL\">Bowlero</a></b> -- fell 21%, 12%, and 12%, respectively, averaging out to a 15% plunge.</p><p>The <b>S&amp;P 500</b> experienced only a 0.7% move lower. I was right. I have been correct in 36 of the past 57 weeks, or 63% of the time.</p><p>Now let&#39;s look at the week ahead. I see <b>Best Buy</b>, <b>Luckin Coffee</b>, and <b>Apple</b> as stocks you might want to consider steering clear of this week. Let&#39;s go over my near-term concerns with all three investments.</p><h2><b>1. Best Buy</b></h2><p>Best Buy&#39;s revival a few years ago was a thing of beauty. Now we&#39;re seeing that the last major consumer-electronics superstore chain still standing is on wobbly legs.</p><p>The retailer reports fresh financials on Tuesday morning, and it won&#39;t be pretty. Analysts see revenue clocking in 13% lower than the prior-year&#39;s fiscal third quarter. Its profit is expected to be cut in half.</p><p>The near-term outlook is uninspiring. Wall Street pros see revenue slipping 11% for the current holiday quarter, as well as the entire fiscal 2023 year that ends in January. Profitability should take a bigger hit. If you&#39;re buying Best Buy for that chunky 4.9% yield, that&#39;s a dicey proposition when its bottom line is going the wrong way.</p><p>Rising costs and the inability of a brick-and-mortar chain to compete on price with bare-boned online merchants are making life hard for Best Buy, again. Now we have a potentially dimming economy setting back demand for consumer electronics.</p><p>To be fair, Best Buy&#39;s renaissance wasn&#39;t that exciting. You have to go back to fiscal 2009 -- 14 years -- to find the last time that this chain delivered top-line gains in the double digits.</p><h2><b>2. Luckin Coffee</b></h2><p>If you were to construct the perfect stock to avoid in a lab, it would probably look a lot like Luckin Coffee. It&#39;s a China-based company at a time when most investors outside of the country are steering clear of the market.</p><p>Let&#39;s also not forget that Luckin Coffee is a stock that -- like its hot java -- already burned investors before. You surely remember the accounting scandal of 2020.</p><p>Have you checked on Luckin Coffee stock lately? The stock is a 20-bagger off its C-suite drama low. The shares ended this past week within 0.5% of a new two-year high, nearly quadrupling from this-year&#39;s springtime bottom. We&#39;ll get an update on how it&#39;s brewing when it pours a cup of third-quarter results on Tuesday.</p><p>Luckin Coffee has done a commendable job turning things around. After years of losses, it was profitable in 2021. Revenue continued to grow.</p><p>However, Luckin Coffee&#39;s top-line gains have decelerated for four consecutive quarters. It also posted a loss in its previous quarter. It&#39;s hard to get excited about Luckin Coffee. It may seem like a low-priced indulgence, but it&#39;s a luxury that consumers will avoid if they need to save their money for more-pressing expenses.</p><h2><b>3. Apple</b></h2><p>Let&#39;s wrap-up this-week&#39;s list by picking on the country&#39;s most valuable company by market cap. I&#39;m a longtime fan and investor in Apple, but I can see why it&#39;s a scary stock to hold heading into this particular holiday shopping season. The economy is on iffy footing, credit card debit is rising, and Apple isn&#39;t going to be immune from consumers steering clear of big-ticket purchases this season.</p><p>Apple held up well when most tech stocks got slammed earlier this year, but the class act of Cupertino is finally proving mortal. It doesn&#39;t help that its annual refresh of popular products wasn&#39;t overly impressive. With money already tight, it&#39;s easy to see consumers ride this year out and see what Apple springs on us in 2023.</p><p>Analysts aren&#39;t excited. They see revenue and earnings per share rising a mere 3% and 2%, respectively, for the new fiscal year.</p><p>It&#39;s going to be a bumpy road for some of these investments. If you&#39;re looking for safe stocks, you aren&#39;t likely to find them in Best Buy, Luckin Coffee, and Apple this week.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Avoid This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Avoid This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-22 11:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last week was a letdown for investors long the market after a strong rally the week before. The \"three stocks to avoid\" in my column that I thought were going to lose to the market last week -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LKNCY":"瑞幸咖啡","AAPL":"苹果","BBY":"百思买"},"source_url":"https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2285904055","content_text":"Last week was a letdown for investors long the market after a strong rally the week before. The \"three stocks to avoid\" in my column that I thought were going to lose to the market last week -- Coinbase, Despegar.com, and Bowlero -- fell 21%, 12%, and 12%, respectively, averaging out to a 15% plunge.The S&P 500 experienced only a 0.7% move lower. I was right. I have been correct in 36 of the past 57 weeks, or 63% of the time.Now let's look at the week ahead. I see Best Buy, Luckin Coffee, and Apple as stocks you might want to consider steering clear of this week. Let's go over my near-term concerns with all three investments.1. Best BuyBest Buy's revival a few years ago was a thing of beauty. Now we're seeing that the last major consumer-electronics superstore chain still standing is on wobbly legs.The retailer reports fresh financials on Tuesday morning, and it won't be pretty. Analysts see revenue clocking in 13% lower than the prior-year's fiscal third quarter. Its profit is expected to be cut in half.The near-term outlook is uninspiring. Wall Street pros see revenue slipping 11% for the current holiday quarter, as well as the entire fiscal 2023 year that ends in January. Profitability should take a bigger hit. If you're buying Best Buy for that chunky 4.9% yield, that's a dicey proposition when its bottom line is going the wrong way.Rising costs and the inability of a brick-and-mortar chain to compete on price with bare-boned online merchants are making life hard for Best Buy, again. Now we have a potentially dimming economy setting back demand for consumer electronics.To be fair, Best Buy's renaissance wasn't that exciting. You have to go back to fiscal 2009 -- 14 years -- to find the last time that this chain delivered top-line gains in the double digits.2. Luckin CoffeeIf you were to construct the perfect stock to avoid in a lab, it would probably look a lot like Luckin Coffee. It's a China-based company at a time when most investors outside of the country are steering clear of the market.Let's also not forget that Luckin Coffee is a stock that -- like its hot java -- already burned investors before. You surely remember the accounting scandal of 2020.Have you checked on Luckin Coffee stock lately? The stock is a 20-bagger off its C-suite drama low. The shares ended this past week within 0.5% of a new two-year high, nearly quadrupling from this-year's springtime bottom. We'll get an update on how it's brewing when it pours a cup of third-quarter results on Tuesday.Luckin Coffee has done a commendable job turning things around. After years of losses, it was profitable in 2021. Revenue continued to grow.However, Luckin Coffee's top-line gains have decelerated for four consecutive quarters. It also posted a loss in its previous quarter. It's hard to get excited about Luckin Coffee. It may seem like a low-priced indulgence, but it's a luxury that consumers will avoid if they need to save their money for more-pressing expenses.3. AppleLet's wrap-up this-week's list by picking on the country's most valuable company by market cap. I'm a longtime fan and investor in Apple, but I can see why it's a scary stock to hold heading into this particular holiday shopping season. The economy is on iffy footing, credit card debit is rising, and Apple isn't going to be immune from consumers steering clear of big-ticket purchases this season.Apple held up well when most tech stocks got slammed earlier this year, but the class act of Cupertino is finally proving mortal. It doesn't help that its annual refresh of popular products wasn't overly impressive. With money already tight, it's easy to see consumers ride this year out and see what Apple springs on us in 2023.Analysts aren't excited. They see revenue and earnings per share rising a mere 3% and 2%, respectively, for the new fiscal year.It's going to be a bumpy road for some of these investments. If you're looking for safe stocks, you aren't likely to find them in Best Buy, Luckin Coffee, and Apple this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1837,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9906810317,"gmtCreate":1659513155742,"gmtModify":1705981153931,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E5H.SI\">$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$</a>gAr","listText":"<a href=\"https://ttm.financial/S/E5H.SI\">$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$</a>gAr","text":"$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$gAr","images":[{"img":"https://community-static.tradeup.com/news/27489d5f9349d6763f3bd7cb71450cf1","width":"1080","height":"3642"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9906810317","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9048611626,"gmtCreate":1656203623965,"gmtModify":1676535783189,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>jiutan","listText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>jiutan","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$jiutan","images":[{"img":"https://community-static.tradeup.com/news/8594cabb9343b3e1370ae799928d6d69","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9048611626","isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9089671151,"gmtCreate":1649990628907,"gmtModify":1676534624249,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>come come come","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>come come come","text":"$FRENCKEN GROUP LIMITED(E28.SI)$come come come","images":[{"img":"https://community-static.tradeup.com/news/2e5143b7530ffd3f9ed1b8e35439a00f","width":"1080","height":"2506"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9089671151","isVote":1,"tweetType":1,"viewCount":621,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9010366877,"gmtCreate":1648260199214,"gmtModify":1676534323174,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"Strong 💪","listText":"Strong 💪","text":"Strong 💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9010366877","repostId":"2222052834","repostType":4,"repost":{"id":"2222052834","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1648249343,"share":"https://ttm.financial/m/news/2222052834?lang=&edition=full_marsco","pubTime":"2022-03-26 07:02","market":"us","language":"en","title":"US STOCKS-S&P 500 Ends Higher with Financials as Treasury Yields Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2222052834","media":"Reuters","summary":"* Financials rise with 10-yr yield* Tech shares down, weighing on Nasdaq* Utilities sector hits reco","content":"<html><head></head><body><p>* Financials rise with 10-yr yield</p><p>* Tech shares down, weighing on Nasdaq</p><p>* Utilities sector hits record high</p><p>* Indexes: Dow up 0.4%, S&amp;P 500 up 0.5%, Nasdaq down 0.2%</p><p>* For the week, Dow up 0.3%, S&amp;P 500 up 1.8%, Nasdaq up 2%</p><p>NEW YORK, March 25 (Reuters) - The S&amp;P 500 ended higher on Friday as financial shares rose after the benchmark Treasury yield jumped to its highest level in nearly three years.</p><p>The Nasdaq ended lower, and tech and other big growth names mostly declined, but they finished off session lows following a late-session rally.</p><p>For the week, the Nasdaq and S&amp;P 500 registered solid gains of 2% and 1.8%, respectively, and the Dow was nominally higher with a 0.3% rise.</p><p>The S&amp;P 500 financials sector gave the S&amp;P 500 its biggest boost on Friday, rising 1.3%, while technology and consumer discretionary sectors were the only two major sectors to end lower on the day.</p><p>Investors are assessing how aggressive the Federal Reserve will be as it tightens policy after Fed Chair Jerome Powell this week said that the central bank needed to move &#34;expeditiously&#34; to combat high inflation and raised the possibility of a 50-basis-point hike in rates in May.</p><p>U.S. Treasury yields jumped on Friday, with the benchmark 10-year note surging to nearly three-year highs, as the market grappled with high inflation and a Federal Reserve that could easily spark a downturn as it aggressively tightens policy.</p><p>Ten-year Treasury yields were last at 2.492% after earlier rising above 2.50% for the first time since May 2019.</p><p>The equity market is pricing in a higher rate environment, said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta.</p><p>That is causing bank stocks to outperform, while &#34;adding more pressure to the riskier elements of the market,&#34; such as growth shares, he said.</p><p>Higher borrowing rates benefit banks, while higher rates are a negative for tech and growth stocks, whose valuations rely more heavily on future cash flows.</p><p>The Dow Jones Industrial Average rose 153.3 points, or 0.44%, to 34,861.24, the S&amp;P 500    gained 22.9 points, or 0.51%, to 4,543.06 and the Nasdaq Composite dropped 22.54 points, or 0.16%, to 14,169.30.</p><p>Shares of growth companies like Nvidia Corp eased after leading a Wall Street rebound earlier this week.</p><p>The utilities sector also rose sharply, hitting a record high as investors favored defensive stocks with the Russia-Ukraine war still raging after a month.</p><p>The sector ended up 1.5% on the day and up 3.5% for the week, while the energy sector ended up 2.3% on the day and jumped more than 7% for the week following sharp gains in oil prices.</p><p>Moscow signaled on Friday it was scaling back its ambitions in Ukraine to focus on territory claimed by Russian-backed separatists.</p><p>Economists at Citibank are expecting four 50 basis points interest rate hikes from the Fed this year, joining other Wall Street banks in forecasting an aggressive tightening path against the backdrop of soaring inflation.</p><p>The U.S. central bank last week raised interest rates for the first time since 2018.</p><p>&#34;The market&#39;s really macro driven,&#34; said Steve DeSanctis, small- and mid-capitalization equity strategist at Jefferies in New York. &#34;Company fundamentals haven&#39;t really mattered.&#34;</p><p>Volume on U.S. exchanges was 11.92 billion shares, compared with the 14.28 billion average for the full session over the last 20 trading days.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.08-to-1 ratio; on Nasdaq, a 1.40-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 57 new 52-week highs and five new lows; the Nasdaq Composite recorded 73 new highs and 79 new lows.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-S&P 500 Ends Higher with Financials as Treasury Yields Jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-S&P 500 Ends Higher with Financials as Treasury Yields Jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-03-26 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* Financials rise with 10-yr yield</p><p>* Tech shares down, weighing on Nasdaq</p><p>* Utilities sector hits record high</p><p>* Indexes: Dow up 0.4%, S&amp;P 500 up 0.5%, Nasdaq down 0.2%</p><p>* For the week, Dow up 0.3%, S&amp;P 500 up 1.8%, Nasdaq up 2%</p><p>NEW YORK, March 25 (Reuters) - The S&amp;P 500 ended higher on Friday as financial shares rose after the benchmark Treasury yield jumped to its highest level in nearly three years.</p><p>The Nasdaq ended lower, and tech and other big growth names mostly declined, but they finished off session lows following a late-session rally.</p><p>For the week, the Nasdaq and S&amp;P 500 registered solid gains of 2% and 1.8%, respectively, and the Dow was nominally higher with a 0.3% rise.</p><p>The S&amp;P 500 financials sector gave the S&amp;P 500 its biggest boost on Friday, rising 1.3%, while technology and consumer discretionary sectors were the only two major sectors to end lower on the day.</p><p>Investors are assessing how aggressive the Federal Reserve will be as it tightens policy after Fed Chair Jerome Powell this week said that the central bank needed to move &#34;expeditiously&#34; to combat high inflation and raised the possibility of a 50-basis-point hike in rates in May.</p><p>U.S. Treasury yields jumped on Friday, with the benchmark 10-year note surging to nearly three-year highs, as the market grappled with high inflation and a Federal Reserve that could easily spark a downturn as it aggressively tightens policy.</p><p>Ten-year Treasury yields were last at 2.492% after earlier rising above 2.50% for the first time since May 2019.</p><p>The equity market is pricing in a higher rate environment, said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta.</p><p>That is causing bank stocks to outperform, while &#34;adding more pressure to the riskier elements of the market,&#34; such as growth shares, he said.</p><p>Higher borrowing rates benefit banks, while higher rates are a negative for tech and growth stocks, whose valuations rely more heavily on future cash flows.</p><p>The Dow Jones Industrial Average rose 153.3 points, or 0.44%, to 34,861.24, the S&amp;P 500    gained 22.9 points, or 0.51%, to 4,543.06 and the Nasdaq Composite dropped 22.54 points, or 0.16%, to 14,169.30.</p><p>Shares of growth companies like Nvidia Corp eased after leading a Wall Street rebound earlier this week.</p><p>The utilities sector also rose sharply, hitting a record high as investors favored defensive stocks with the Russia-Ukraine war still raging after a month.</p><p>The sector ended up 1.5% on the day and up 3.5% for the week, while the energy sector ended up 2.3% on the day and jumped more than 7% for the week following sharp gains in oil prices.</p><p>Moscow signaled on Friday it was scaling back its ambitions in Ukraine to focus on territory claimed by Russian-backed separatists.</p><p>Economists at Citibank are expecting four 50 basis points interest rate hikes from the Fed this year, joining other Wall Street banks in forecasting an aggressive tightening path against the backdrop of soaring inflation.</p><p>The U.S. central bank last week raised interest rates for the first time since 2018.</p><p>&#34;The market&#39;s really macro driven,&#34; said Steve DeSanctis, small- and mid-capitalization equity strategist at Jefferies in New York. &#34;Company fundamentals haven&#39;t really mattered.&#34;</p><p>Volume on U.S. exchanges was 11.92 billion shares, compared with the 14.28 billion average for the full session over the last 20 trading days.</p><p>Advancing issues outnumbered declining ones on the NYSE by a 1.08-to-1 ratio; on Nasdaq, a 1.40-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 57 new 52-week highs and five new lows; the Nasdaq Composite recorded 73 new highs and 79 new lows.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF","IVV":"标普500指数ETF",".IXIC":"NASDAQ Composite","BK4581":"高盛持仓","BK4504":"桥水持仓","OEX":"标普100","OEF":"标普100指数ETF-iShares","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯","SDS":"两倍做空标普500ETF","SPXU":"三倍做空标普500ETF","BK4534":"瑞士信贷持仓","SPY":"标普500ETF","SH":"标普500反向ETF","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2222052834","content_text":"* Financials rise with 10-yr yield* Tech shares down, weighing on Nasdaq* Utilities sector hits record high* Indexes: Dow up 0.4%, S&P 500 up 0.5%, Nasdaq down 0.2%* For the week, Dow up 0.3%, S&P 500 up 1.8%, Nasdaq up 2%NEW YORK, March 25 (Reuters) - The S&P 500 ended higher on Friday as financial shares rose after the benchmark Treasury yield jumped to its highest level in nearly three years.The Nasdaq ended lower, and tech and other big growth names mostly declined, but they finished off session lows following a late-session rally.For the week, the Nasdaq and S&P 500 registered solid gains of 2% and 1.8%, respectively, and the Dow was nominally higher with a 0.3% rise.The S&P 500 financials sector gave the S&P 500 its biggest boost on Friday, rising 1.3%, while technology and consumer discretionary sectors were the only two major sectors to end lower on the day.Investors are assessing how aggressive the Federal Reserve will be as it tightens policy after Fed Chair Jerome Powell this week said that the central bank needed to move \"expeditiously\" to combat high inflation and raised the possibility of a 50-basis-point hike in rates in May.U.S. Treasury yields jumped on Friday, with the benchmark 10-year note surging to nearly three-year highs, as the market grappled with high inflation and a Federal Reserve that could easily spark a downturn as it aggressively tightens policy.Ten-year Treasury yields were last at 2.492% after earlier rising above 2.50% for the first time since May 2019.The equity market is pricing in a higher rate environment, said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta.That is causing bank stocks to outperform, while \"adding more pressure to the riskier elements of the market,\" such as growth shares, he said.Higher borrowing rates benefit banks, while higher rates are a negative for tech and growth stocks, whose valuations rely more heavily on future cash flows.The Dow Jones Industrial Average rose 153.3 points, or 0.44%, to 34,861.24, the S&P 500    gained 22.9 points, or 0.51%, to 4,543.06 and the Nasdaq Composite dropped 22.54 points, or 0.16%, to 14,169.30.Shares of growth companies like Nvidia Corp eased after leading a Wall Street rebound earlier this week.The utilities sector also rose sharply, hitting a record high as investors favored defensive stocks with the Russia-Ukraine war still raging after a month.The sector ended up 1.5% on the day and up 3.5% for the week, while the energy sector ended up 2.3% on the day and jumped more than 7% for the week following sharp gains in oil prices.Moscow signaled on Friday it was scaling back its ambitions in Ukraine to focus on territory claimed by Russian-backed separatists.Economists at Citibank are expecting four 50 basis points interest rate hikes from the Fed this year, joining other Wall Street banks in forecasting an aggressive tightening path against the backdrop of soaring inflation.The U.S. central bank last week raised interest rates for the first time since 2018.\"The market's really macro driven,\" said Steve DeSanctis, small- and mid-capitalization equity strategist at Jefferies in New York. \"Company fundamentals haven't really mattered.\"Volume on U.S. exchanges was 11.92 billion shares, compared with the 14.28 billion average for the full session over the last 20 trading days.Advancing issues outnumbered declining ones on the NYSE by a 1.08-to-1 ratio; on Nasdaq, a 1.40-to-1 ratio favored decliners.The S&P 500 posted 57 new 52-week highs and five new lows; the Nasdaq Composite recorded 73 new highs and 79 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":444,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094193539,"gmtCreate":1645073387899,"gmtModify":1676533994617,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"Like it&nbsp;","listText":"Like it&nbsp;","text":"Like it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9094193539","repostId":"2211661523","repostType":4,"repost":{"id":"2211661523","kind":"highlight","pubTimestamp":1645057250,"share":"https://ttm.financial/m/news/2211661523?lang=&edition=full_marsco","pubTime":"2022-02-17 08:20","market":"us","language":"en","title":"2 Warren Buffett Stocks to Buy and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=2211661523","media":"Motley Fool","summary":"The Oracle of Omaha has historically beaten the market, so it might not be a bad thing to pick up a few tips from him.","content":"<html><head></head><body><p>Warren Buffett, CEO of multinational conglomerate <b>Berkshire Hathaway</b>, is widely regarded as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach to investing and perhaps even get some much-needed inspiration from his stock picks.</p><p>Buffett oversees his company&#39;s investment portfolio, and two stocks in there that are most definitely worth buying and holding onto today are drugmaker <b>AbbVie</b> (NYSE:ABBV) and tech giant <b>Apple</b> (NASDAQ:AAPL). Here&#39;s why.</p><p><img src=\"https://static.tigerbbs.com/cbce34f9cdc257bf6d296c2baea0e809\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>ABBV Total Return Level data by YCharts</p><h2>1. AbbVie</h2><p>Pharmaceutical companies have the advantage of offering products that are always in demand. AbbVie&#39;s portfolio includes immunology drugs Humira, Skyrizi, and Rinvoq; cancer medicines Imbruvica and Venclexta; and schizophrenia treatment Vraylar.</p><p>In 2021, AbbVie&#39;s net revenue came in at $56.1 billion, 10.5% higher than the year-ago period. That&#39;s a solid top-line performance for a pharma giant. The drugmaker&#39;s adjusted earnings per share for the year increased 20.3% to $12.70. Note that AbbVie&#39;s Humira made up almost 37% of the company&#39;s total revenue last year.</p><p>That is a problem since the healthcare company will lose patent exclusivity for this medicine in the U.S. next year. Humira&#39;s loss of patent exclusivity in Europe back in 2018 significantly harmed its international revenue.</p><p>Still, the company is prepared to deal with the inevitable revenue losses Humira will experience in the U.S. in the coming years. Skyrizi and Rinvoq are well on their way to earning approvals across most of Humira&#39;s indications, and they already have significant wins under their belt. In 2021, Sales of Rinvoq more than doubled to $1.7 billion while revenue from Skyrizi increased by 85% to $2.9 billion.</p><p>Skyrizi and Rinvoq seem well-equipped to fill the gaping hole that Humira will leave, but the company can count on its other products as well, including its Botox franchise. Many of the company&#39;s products boast patents that won&#39;t expire anytime soon. Plus, AbbVie has a pipeline with dozens of ongoing programs. Expect new approvals and label expansions to add to the company&#39;s revenue base routinely.</p><p>AbbVie&#39;s solid business helps support its excellent dividend track record. The company is part of the exclusive club of Dividend Kings, or companies that have raised their payouts for at least 50 consecutive years. And with an above-average yield of 3.74% and a conservative payout ratio of 42%, AbbVie looks more than able to sustain further dividend increases ahead.</p><p>That&#39;s just one more reason to purchase shares of this pharma giant. Overall, AbbVie looks like a solid company to hold on to through thick and thin.</p><h2>2. Apple</h2><p>Apple&#39;s iPhone has been immensely successful since it was introduced in 2007. The company remains a leader in this industry with a 22% share of the smartphone market in the fourth quarter of 2021. During its fiscal year 2021 (ended Sept. 25), Apple generated $192 billion in sales from its iPhone segment, 39.3% higher than the previous fiscal year.</p><p>Could Apple lose its dominance in the smartphone market? It wouldn&#39;t be the first time something like that happens. Apple itself played an instrumental role in the decline of <b>BlackBerry</b>&#39;s once-booming smartphone business starting in the late 2000s. Could other companies permanently dethrone Apple?</p><p>Given how popular and powerful the company&#39;s brand has become, it is hard to imagine Apple no longer being one of the most prominent players in this field, at least for the foreseeable future. More importantly, though, Apple has leveraged its strong brand name and robust cash flow generation to invest in and grow its services business.</p><p>The company&#39;s services segment offers customers a range of products, including Apple Music, Apple TV+, Apple Pay, iCloud, and more. The great thing about this business is that it offers much juicier margins than the sale of hardware products such as the iPhone, tablets, and laptops. In other words, as Apple&#39;s services revenue grows -- and as it captures a larger share of the company&#39;s total revenue -- that will work wonders for the company&#39;s bottom line.</p><p>iPhone sales will likely remain strong for many more years, especially as Apple makes headway into various international markets. But the company&#39;s future is increasingly tied to its services segment, and that&#39;s something that should excite investors. Even with a $2.8 trillion market cap, Apple still has considerable room to grow. No wonder it is one of the largest holdings in Buffett&#39;s portfolio.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Stocks to Buy and Hold Forever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Stocks to Buy and Hold Forever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-17 08:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett, CEO of multinational conglomerate Berkshire Hathaway, is widely regarded as one of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211661523","content_text":"Warren Buffett, CEO of multinational conglomerate Berkshire Hathaway, is widely regarded as one of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach to investing and perhaps even get some much-needed inspiration from his stock picks.Buffett oversees his company's investment portfolio, and two stocks in there that are most definitely worth buying and holding onto today are drugmaker AbbVie (NYSE:ABBV) and tech giant Apple (NASDAQ:AAPL). Here's why.ABBV Total Return Level data by YCharts1. AbbViePharmaceutical companies have the advantage of offering products that are always in demand. AbbVie's portfolio includes immunology drugs Humira, Skyrizi, and Rinvoq; cancer medicines Imbruvica and Venclexta; and schizophrenia treatment Vraylar.In 2021, AbbVie's net revenue came in at $56.1 billion, 10.5% higher than the year-ago period. That's a solid top-line performance for a pharma giant. The drugmaker's adjusted earnings per share for the year increased 20.3% to $12.70. Note that AbbVie's Humira made up almost 37% of the company's total revenue last year.That is a problem since the healthcare company will lose patent exclusivity for this medicine in the U.S. next year. Humira's loss of patent exclusivity in Europe back in 2018 significantly harmed its international revenue.Still, the company is prepared to deal with the inevitable revenue losses Humira will experience in the U.S. in the coming years. Skyrizi and Rinvoq are well on their way to earning approvals across most of Humira's indications, and they already have significant wins under their belt. In 2021, Sales of Rinvoq more than doubled to $1.7 billion while revenue from Skyrizi increased by 85% to $2.9 billion.Skyrizi and Rinvoq seem well-equipped to fill the gaping hole that Humira will leave, but the company can count on its other products as well, including its Botox franchise. Many of the company's products boast patents that won't expire anytime soon. Plus, AbbVie has a pipeline with dozens of ongoing programs. Expect new approvals and label expansions to add to the company's revenue base routinely.AbbVie's solid business helps support its excellent dividend track record. The company is part of the exclusive club of Dividend Kings, or companies that have raised their payouts for at least 50 consecutive years. And with an above-average yield of 3.74% and a conservative payout ratio of 42%, AbbVie looks more than able to sustain further dividend increases ahead.That's just one more reason to purchase shares of this pharma giant. Overall, AbbVie looks like a solid company to hold on to through thick and thin.2. AppleApple's iPhone has been immensely successful since it was introduced in 2007. The company remains a leader in this industry with a 22% share of the smartphone market in the fourth quarter of 2021. During its fiscal year 2021 (ended Sept. 25), Apple generated $192 billion in sales from its iPhone segment, 39.3% higher than the previous fiscal year.Could Apple lose its dominance in the smartphone market? It wouldn't be the first time something like that happens. Apple itself played an instrumental role in the decline of BlackBerry's once-booming smartphone business starting in the late 2000s. Could other companies permanently dethrone Apple?Given how popular and powerful the company's brand has become, it is hard to imagine Apple no longer being one of the most prominent players in this field, at least for the foreseeable future. More importantly, though, Apple has leveraged its strong brand name and robust cash flow generation to invest in and grow its services business.The company's services segment offers customers a range of products, including Apple Music, Apple TV+, Apple Pay, iCloud, and more. The great thing about this business is that it offers much juicier margins than the sale of hardware products such as the iPhone, tablets, and laptops. In other words, as Apple's services revenue grows -- and as it captures a larger share of the company's total revenue -- that will work wonders for the company's bottom line.iPhone sales will likely remain strong for many more years, especially as Apple makes headway into various international markets. But the company's future is increasingly tied to its services segment, and that's something that should excite investors. Even with a $2.8 trillion market cap, Apple still has considerable room to grow. No wonder it is one of the largest holdings in Buffett's portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9932748204,"gmtCreate":1662997052808,"gmtModify":1676537179450,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>JIUTIAN","listText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>JIUTIAN","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$JIUTIAN","images":[{"img":"https://community-static.tradeup.com/news/d6f4d1de132e9ca046259f661303ab4a","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/9932748204","isVote":1,"tweetType":1,"viewCount":1529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9991420815,"gmtCreate":1660871739539,"gmtModify":1676536415267,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573516985440152","authorIdStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/5CP.SI\">$SILVERLAKE AXIS LTD(5CP.SI)$</a>silverlake","listText":"<a href=\"https://ttm.financial/S/5CP.SI\">$SILVERLAKE AXIS LTD(5CP.SI)$</a>silverlake","text":"$SILVERLAKE AXIS LTD(5CP.SI)$silverlake","images":[{"img":"https://community-static.tradeup.com/news/e8c3c478aef16eb854490284dc43205c","width":"1080","height":"2492"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/9991420815","isVote":1,"tweetType":1,"viewCount":947,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}